Crohn's Ileocolitis
10
4
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (10)
Effect of Statins on Crohn's Disease
Safety Study of P28GST Treatment in Crohn's Disease Patients
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
A Pilot Study to Explore the Role of Gut Flora in Crohn's Disease
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
Comparing Manual Versus Stapled Side to Side Ileocolic Anastomosis in Crohn's Disease
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease
PAtophysiological, Nodal-based Approach for Crohn's Disease Excision